Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2021
A Comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF, and <sup>18</sup>F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, et al.
Clinical Nuclear Medicine
|
August 15, 2017
18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology
Baris Turkbey, Esther Mena, Liza Lindenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2025
Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers
Frank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2025
Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers
Frank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
Andrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
The Lancet. Haematology
|
December 18, 2017
Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study
Kirsten M Williams, Jennifer Holter-Chakrabarty, Liza Lindenberg, et al.
Oncotarget
|
November 2, 2017
Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using <sup>64</sup>Cu-plerixafor PET
Ido D Weiss, Lyn M Huff, Moses O Evbuomwan, et al.
Oncotarget
|
October 24, 2018
Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using <sup>64</sup>Cu-plerixafor PET
Ido D Weiss, Lyn M Huff, Moses O Evbuomwan, et al.
The Oncologist
|
February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma
Dickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2021
A Comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF, and <sup>18</sup>F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, et al.
Clinical Nuclear Medicine
|
August 15, 2017
18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology
Baris Turkbey, Esther Mena, Liza Lindenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2025
Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers
Frank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2025
Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers
Frank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
Andrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
<sup>18</sup>F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, et al.
The Lancet. Haematology
|
December 18, 2017
Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study
Kirsten M Williams, Jennifer Holter-Chakrabarty, Liza Lindenberg, et al.
Oncotarget
|
November 2, 2017
Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using <sup>64</sup>Cu-plerixafor PET
Ido D Weiss, Lyn M Huff, Moses O Evbuomwan, et al.
Oncotarget
|
October 24, 2018
Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using <sup>64</sup>Cu-plerixafor PET
Ido D Weiss, Lyn M Huff, Moses O Evbuomwan, et al.
The Oncologist
|
February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma
Dickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
Page
of 9